| John D Ingram, MD | |
|
2016 1st Ave S, Denison, IA 51442-2210 | |
| (712) 263-3388 | |
| (712) 263-1777 |
| Full Name | John D Ingram |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 32 Years |
| Location | 2016 1st Ave S, Denison, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205838984 | NPI | - | NPPES |
| 3086918 | Medicaid | IA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 29356 (Iowa) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Angels Care Home Health Of Iowa | Council bluffs, IA | Home health agency |
| St Croix Hospice | Co bluffs, IA | Hospice |
| Crawford County Memorial Hospital | Denison, IA | Hospital |
| The Nebraska Medical Center | Omaha, NE | Hospital |
| St Anthony Regional Hospital & Nursing Home | Carroll, IA | Hospital |
| Eventide Lutheran Home For The | Denison, IA | Nursing home |
| Denison Care Center | Denison, IA | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Crawford County Memorial Hospital | 7810890555 | 14 |
News Archive
EnVivo Pharmaceuticals, a company dedicated to developing a broad range of novel therapies for central nervous system diseases, today announced it has initiated COGNITIV AD, a Phase 3 clinical program evaluating its novel alpha-7 (α7) potentiator, encenicline-hydrochloride (EVP-6124), in patients with Alzheimer's disease. The program is being conducted under a Special Protocol Assessment agreement with the FDA.
The health statistics are heart-stopping for Hispanic communities: the leading cause of death among both Hispanic men and women is cardiovascular disease.
An international research team led by the University of California, Irvine has identified a system of communication networks that exists among organs and tissues that regulate metabolism.
EpiCept Corporation today announced operating and financial results for the three months ended March 31, 2010, and provided an update with respect to the Company's key business initiatives.
The prognosis for nearly three-quarters of elderly patients on intensive chemotherapy for acute myeloid leukemia (AML) is poor, with a median survival of less than six months, according to a study published online today in Blood, the journal of the American Society of Hematology. AML is the most common form of acute leukemia among adults and is a rapidly growing cancer of the bone marrow that requires immediate treatment. The average age at diagnosis is 67, and more than 12,000 people will be diagnosed with AML this year (according to the National Cancer Institute).
› Verified 9 days ago
| Entity Name | Crawford County Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619969086 PECOS PAC ID: 7810890555 Enrollment ID: O20040129000821 |
News Archive
EnVivo Pharmaceuticals, a company dedicated to developing a broad range of novel therapies for central nervous system diseases, today announced it has initiated COGNITIV AD, a Phase 3 clinical program evaluating its novel alpha-7 (α7) potentiator, encenicline-hydrochloride (EVP-6124), in patients with Alzheimer's disease. The program is being conducted under a Special Protocol Assessment agreement with the FDA.
The health statistics are heart-stopping for Hispanic communities: the leading cause of death among both Hispanic men and women is cardiovascular disease.
An international research team led by the University of California, Irvine has identified a system of communication networks that exists among organs and tissues that regulate metabolism.
EpiCept Corporation today announced operating and financial results for the three months ended March 31, 2010, and provided an update with respect to the Company's key business initiatives.
The prognosis for nearly three-quarters of elderly patients on intensive chemotherapy for acute myeloid leukemia (AML) is poor, with a median survival of less than six months, according to a study published online today in Blood, the journal of the American Society of Hematology. AML is the most common form of acute leukemia among adults and is a rapidly growing cancer of the bone marrow that requires immediate treatment. The average age at diagnosis is 67, and more than 12,000 people will be diagnosed with AML this year (according to the National Cancer Institute).
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John D Ingram, MD 100 Medical Pkwy, Ste A, Denison, IA 51442-2614 Ph: (712) 263-3388 | John D Ingram, MD 2016 1st Ave S, Denison, IA 51442-2210 Ph: (712) 263-3388 |
News Archive
EnVivo Pharmaceuticals, a company dedicated to developing a broad range of novel therapies for central nervous system diseases, today announced it has initiated COGNITIV AD, a Phase 3 clinical program evaluating its novel alpha-7 (α7) potentiator, encenicline-hydrochloride (EVP-6124), in patients with Alzheimer's disease. The program is being conducted under a Special Protocol Assessment agreement with the FDA.
The health statistics are heart-stopping for Hispanic communities: the leading cause of death among both Hispanic men and women is cardiovascular disease.
An international research team led by the University of California, Irvine has identified a system of communication networks that exists among organs and tissues that regulate metabolism.
EpiCept Corporation today announced operating and financial results for the three months ended March 31, 2010, and provided an update with respect to the Company's key business initiatives.
The prognosis for nearly three-quarters of elderly patients on intensive chemotherapy for acute myeloid leukemia (AML) is poor, with a median survival of less than six months, according to a study published online today in Blood, the journal of the American Society of Hematology. AML is the most common form of acute leukemia among adults and is a rapidly growing cancer of the bone marrow that requires immediate treatment. The average age at diagnosis is 67, and more than 12,000 people will be diagnosed with AML this year (according to the National Cancer Institute).
› Verified 9 days ago
Michael P Luft, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 Medical Pkwy Ste A, Denison, IA 51442 Phone: 712-265-2700 Fax: 712-263-1777 | |
Rose Mary Mason, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1820 Hwy 30 E, Denison, IA 51442 Phone: 712-263-6116 Fax: 712-263-6115 | |
Dr. David Marc Tan Creti, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1820 Hwy 30 E, Denison, IA 51442 Phone: 712-263-6116 Fax: 712-263-6115 | |
Patrick Luft, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 Medical Pkwy, Denison, IA 51442 Phone: 712-265-2500 | |
Alisha E Mor, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 Medical Pkwy, Ste A, Denison, IA 51442 Phone: 712-265-2561 | |
John Lothrop Iii, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 Medical Pkwy Ste A, Denison, IA 51442 Phone: 712-265-2700 |